Inactive

The purpose of this acquisition is to obtain services, personnel, equipment and facilities as required to perform (a) both cGMP (Good Manufacturing Practices) and non-GMP synthesis of and (b) analytic... The purpose of this acquisition is to obtain services, personnel, equipment and facilities as required to perform (a) both cGMP (Good Manufacturing Practices) and non-GMP synthesis of and (b) analytical method development and analyses of bulk drug substances and formulated drug products under cGMP conditions. "Synthesis" shall hereafter refer to both cGMP and non-GMP synthesis. Please refere to the attache Request For Proposal (RFP) 75N91022R00015 for details. Deadline for receipt of questions is July 29, 2022 at 2:00 PM EDT. Deadline for receipt of proposals is August 15, 2022 at 3:00 PM EDT. Amendment 1 is issued. The purpose of this Amendment is to answer Offerors questions and extend the proposal due date to September 8 at 12:00 PM EDT.

Inactive

Please see the attached documents related to the Presolicitation Notice for RFP No. 75N91022R00015, titled "Synthesis of GMP and Non-GMP Bulk Drugs Material and Analysis of Bulk Drugs & Pharmaceutical... Please see the attached documents related to the Presolicitation Notice for RFP No. 75N91022R00015, titled "Synthesis of GMP and Non-GMP Bulk Drugs Material and Analysis of Bulk Drugs & Pharmaceutical Formulations".